TCL-416: Updated Clinical Data From the Phase 1/2 Study of Dibotatug (DR-01), a Non-Fucosylated Anti-CD94 Antibody, in Patients With Relapsed/Refractory Cytotoxic T/NK Cell Lymphomas
Swaminathan Iyer, Christina Poh, Jasmine Zain, Christiane Querfeld et autres
us, au, it, hk, kr, py (code pays fourni par la source)